abstract |
The present description refers to 1 - {[4- (methoxymethyl) -4 - ({[(1R, 2S) -2-phenylcyclopropyl] amino} methyl) piperidin-1-yl] methyl} cyclobutanecarboxylic acid tosylate salts, methods for its preparation and intermediates in its preparation, which are useful in the treatment of diseases associated with or mediated by LSD1, such as cancer. |